扬农化工(600486) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 3,240,624,091.42, representing a year-on-year increase of 2.04% compared to CNY 3,175,722,146.35 in Q1 2024[5] - The net profit attributable to shareholders for Q1 2025 was CNY 434,934,070.10, a 1.35% increase from CNY 429,124,709.66 in the same period last year[5] - The basic earnings per share for Q1 2025 was CNY 1.069, up 1.27% from CNY 1.056 in Q1 2024[5] - Operating profit for Q1 2025 was ¥518,164,874.08, up from ¥500,067,033.76 in Q1 2024, reflecting a growth of 3.1%[23] - The company reported a net profit margin improvement, with profit before tax at ¥513,401,768.33, compared to ¥500,065,482.56 in the previous year[23] - The net profit for Q1 2025 was CNY 435,108,496.60, a slight increase of 1.99% compared to CNY 429,255,744.17 in Q1 2024[25] - The basic and diluted earnings per share for Q1 2025 were both CNY 1.069, up from CNY 1.056 in Q1 2024, reflecting a growth of 1.23%[25] Cash Flow and Investments - The net cash flow from operating activities decreased by 9.05% to CNY 1,030,478,722.88 from CNY 1,132,964,225.39 in Q1 2024[5] - Cash flow from operating activities for Q1 2025 was CNY 1,030,478,722.88, down 9.02% from CNY 1,132,964,225.39 in Q1 2024[29] - Cash flow from investing activities showed a net outflow of CNY 216,944,412.17 in Q1 2025, compared to a smaller outflow of CNY 100,986,815.93 in Q1 2024[30] - Cash inflow from investment activities was CNY 84,306,443.08 in Q1 2025, down from CNY 305,785,176.07 in Q1 2024[30] - Cash flow from financing activities resulted in a net outflow of CNY 215,913,876.35 in Q1 2025, contrasting with a net inflow of CNY 293,088,157.96 in Q1 2024[30] Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 18,075,562,084.89, reflecting a 2.33% increase from CNY 17,664,818,218.90 at the end of the previous year[5] - Current assets increased to ¥7,763,322,683.32 from ¥7,181,950,809.61, representing an increase of 8.1%[18] - Total liabilities decreased slightly to ¥7,087,167,854.79 from ¥7,122,251,673.36, a reduction of 0.49%[20] - The company's cash and cash equivalents rose to ¥1,843,456,848.35 from ¥1,618,026,888.46, marking an increase of 13.9%[18] - Total cash and cash equivalents at the end of Q1 2025 amounted to CNY 1,274,109,062.96, a decrease from CNY 1,854,504,023.19 at the end of Q1 2024[30] Shareholder Information - The company had a total of 19,246 common shareholders at the end of the reporting period[10] - The largest shareholder, Syngenta Group Co., Ltd., held 145,710,256 shares, accounting for 35.83% of the total shares[10] Research and Development - Research and development expenses for Q1 2025 were ¥78,799,984.11, compared to ¥75,288,585.24 in Q1 2024, reflecting a growth of 6.7%[23] Other Financial Metrics - Non-recurring gains and losses totaled CNY 4,631,786.68 for the period, after accounting for tax effects[8] - The equity attributable to shareholders increased by 4.23% to CNY 10,981,570,529.30 from CNY 10,535,931,053.30 at the end of the previous year[5] - The total equity attributable to shareholders increased to ¥10,981,570,529.30 from ¥10,535,931,053.30, an increase of 4.22%[20] - The weighted average return on equity decreased by 0.29 percentage points to 4.04% from 4.34% in the previous year[5] - The company reported a decrease in comprehensive income total to CNY 433,794,959.01 in Q1 2025, compared to CNY 438,419,313.59 in Q1 2024[25] - The total revenue from sales in Q1 2025 was CNY 3,069,084,108.32, a decrease of 3.55% from CNY 3,182,554,798.04 in Q1 2024[29] - The company received CNY 80,445,236.88 in tax refunds during Q1 2025, slightly down from CNY 81,066,572.36 in Q1 2024[29] - Inventory levels decreased to ¥1,022,591,627.19 from ¥1,104,865,027.32, a decline of 7.43%[18]